Indeed, patients lacking VWF (von Willebrand disease (VWD) type 3)) not only have a secondary deficiency of FVIII, but also a strongly reduced half-life of intravenously administered FVIII [4]. This evidence concerns the gene F8 and platelet-type von Willebrand disease.